Transcatheter closure of atrial septal defect and patent foramen ovale with Carag bioresorbable septal occluder: first-in-man experience with 24-month follow-up-Reference-Cited by-同舟云学术

Transcatheter closure of atrial septal defect and patent foramen ovale with Carag bioresorbable septal occluder: first-in-man experience with 24-month follow-up

Published:2022-04 Issue:18 Volume:17 Page:1536-1537
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:

Author:

Sievert Kolja,Bertog Stefan,Söderberg Björn,Gafoor Sameer,Hofmann Ilona,Grunwald Iris,Schnelle Nalan,Sievert Horst

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Reference2 articles.

1. Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder

2. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Development of Biodegradable Occlusion Devices for Intra-Atrial Shunts;Reviews in Cardiovascular Medicine;2024-05-08

2. Biodegradable Cardiac Occluder with Surface Modification by Gelatin–Peptide Conjugate to Promote Endogenous Tissue Regeneration;Advanced Science;2023-11-20

3. Progress of biodegradable polymer application in cardiac occluders;Journal of Biomedical Materials Research Part B: Applied Biomaterials;2023-11-16

4. Fully bioabsorbable devices—key development in the treatment of structural and congenital heart disease?;Science Bulletin;2023-08

5. Transcatheter closure of perimembranous ventricular septal defect using a novel fully bioabsorbable occluder: multicenter randomized controlled trial;Science Bulletin;2023-05